Effects of Intra-Aortic Balloon Counterpulsation on Parameters of Tissue Oxygenation
To investigate the effects of intra-aortic balloon pump therapy on parameters of global and regional oxygenation in patients undergoing cardiac surgery.
A Perfusion Conference at Sea October 13-21, 2007
A cruise conference is a unique alternative to traditional land-based resort programs as less expensive. Group cruising offers visual activity while interfacing conference participants in a relaxed and pleasurable setting. A cruise meeting will motivate-inspire-educate-revitalize attendees at sea with all the luxury and elegance that only an ocean liner offers in a self contained environment. We assure that the objectives-expectations-budget allocations will be achieved as an excellent return on your investment.
PHVT Disruptive Technology Could Revolutionize Heart Failure Treatment
The early clinical promise of percutaneous heart valve technology-a group of minimally invasive devices designed to treat cardiac valve dysfunction without the need for cardiopulmonary bypass-could one day play a prominent role in curbing the costs associated with treating heart failure, which is the current number-one driver of hospitalization among Medicare patients.
The Risk Associated with Aprotinin in Cardiac Surgery
In this observational study involving 4374 patients undergoing revascularization, we prospectively assessed three agents (aprotinin [1295 patients], aminocaproic acid [883], and tranexamic acid [822]) as compared with no agent (1374 patients) with regard to serious outcomes by propensity and multivariable methods.
The Risk Associated with Aprotinin in Cardiac Surgery
In this observational study involving 4374 patients undergoing revascularization, we prospectively assessed three agents (aprotinin [1295 patients], aminocaproic acid [883], and tranexamic acid [822]) as compared with no agent (1374 patients) with regard to serious outcomes by propensity and multivariable methods.
The Risk Associated with Aprotinin in Cardiac Surgery
In this observational study involving 4374 patients undergoing revascularization, we prospectively assessed three agents (aprotinin [1295 patients], aminocaproic acid [883], and tranexamic acid [822]) as compared with no agent (1374 patients) with regard to serious outcomes by propensity and multivariable methods.
Bayer HealthCare Response: The Risk Associated with Aprotinin in Cardiac Surgery
Bayer has only just become aware of this observational study and we have not yet had an opportunity to receive and review the data from which the authors derived their conclusions.
Blood Warm Reperfusion: A Necessary Adjunct to Heart-Valve Surgery in Low-Risk Patients?
The aim of this prospective, randomized study was to determine whether blood warm reperfusion improves myocardial protection provided by cold crystalloid cardioplegia in patients undergoing first-time elective heart-valve surgery, using cardiac troponin I release as the criterion for evaluating the adequacy of myocardial protection.
Influence of Venous Drainage and Hemofiltration on Hypercirculatory Instability After High Volume Crystalloid Cardioplegia During Coronary Artery Bypass Surgery
This prospective study was undertaken in order to investigate the impact of the systemic infusion of high volume crystalloid cardioplegia on the incidence of hypercirculatory instability and inflammatory mediator release in patients undergoing coronary artery bypass grafting.
Comparison of ACT Point-Of-Care Measurements: Repeatability and Agreement
This study was designed to determine if the activated coagulation time (ACT) values of each analyser separately are repeatable, and to determine whether there exists a significant difference in ACT values measured by three different analyzers.
The Inflammatory Response to Cardiopulmonary Bypass: A Therapeutic Overview
In this review, we will provide an overview of integrated therapeutic strategies that can be utilized to minimize the complex and myriad changes related to inflammation after CPB with the understanding that this may abrogate the detrimental end-organ and systemic effects of blood activation.
Reliability of Point-Of-Care Hematocrit, Blood Gas, Electrolyte, Lactate and Glucose Measurement During Cardiopulmonary Bypass
In this prospective clinical study, the analytical performance of the GEM Premier 3000 was compared with the Ciba Corning 865 analyser for blood gas/electrolytes/metabolites, and for hematocrit with the Sysmex XE 2100 instrument.